![](https://www.mintz.com/sites/default/files/styles/bio_banner/public/media/images/2019-09-24/Professional_Cropped_Civetta_Alexander_Mintz.jpg?itok=4R8szIps)
Alex advises companies on the intersection of law and business, with an emphasis on entrepreneurship, technology transactions, and negotiation. He regularly handles licensing agreements, key commercial contracts, and financing matters for innovators in the software, technology, professional services, and biotechnology industries. In 2021 and 2022, Alex was named a Top Lawyer in Corporate Law by Boston Magazine; in 2022, Alex was nationally ranked in Chambers USA for Start Ups and Emerging Companies. He has taught venture capital law at Boston University School of Law and is a regular speaker at client trainings on everything from raising seed capital to negotiating company-defining collaboration agreements.
Alex is particularly focused on using interest-based negotiation to get the best possible results for his clients. He was previously a teaching assistant for negotiation courses at Harvard Law School, the Massachusetts Institute of Technology’s Sloan School of Management, and various executive education programs through Harvard’s Program on Negotiation. He also served as managing editor of the Harvard Negotiation Law Review. Alex facilitates negotiation trainings and workshops for companies and other institutions on a consulting basis.
Before Alex attended law school, he was a senior program manager at a private software-as-a-service company, where he advised clients on complex software integration projects.
Experience
Examples of recent commercial and licensing transactions include:
- $100m+ exclusive licensing deal opposite a major media company
- $40m sponsorship deal on behalf of a sportswear brand opposite a professional sports league
- $250m+ long-term cross-border supply and services agreement in wafer technology
- Long-term strategic partnership and integration agreement for a loan trading platform opposite a large bank
- Software development and SAAS integration deal for AI-assisted tools opposite Fortune 50 retailer
- Out-license of platform technologies and patent families out of MIT and Harvard
- Grant agreement and long-term IP-related partnership between a venture fund and a large research institution
- Company-critical 3PL deal on behalf of an ecommerce-based retailer
- Strategic partnership and exclusive distribution agreement on behalf of a water filtration technology company
- Development and distribution agreement for a smart-home technology provider opposite a major solar integrator
Examples of recent financing transactions include:
- SAFE and side letter financings for multiple startups opposite incubator programs from top venture firms
- $30m Series B financing for SAAS company, including 30+ transaction secondary sale alongside
- $20m Series A financing for digital health company including strategic investors
- $22m convertible debt deal for a gene editing company opposite a Singaporean government entity among other investors
- $35m Series A financing for health care technology company, including secondary sale alongside
- $12m Series Seed financing for synthetic biology MIT spinout
- $7m Series A financing for gut biome medical device MIT spinout
viewpoints
Energy & Sustainability Client Feature — Cultivo
March 1, 2024 | Article | By Alex Civetta
Read about Cultivo, a public benefit corporation, and its recent $14 million in Series A funding to be used to advance the development of Cultivo’s AI-driven platform for large-scale nature regeneration projects.
Six Common Contract Traps: A Field Guide
March 25, 2022 | Advisory | By Alex Civetta
Read our guide to common contract traps emerging technology companies can face when negotiating contracts with large customers that have a master services agreement, including disadvantageous terms and the omission of clauses that protect vendors.
Stock Vesting in Startup Companies
March 15, 2022 | Article | By Alex Civetta, Garrett Galvin
Enforcing Click-Through and URL Terms
March 30, 2021 | Advisory | By Alex Civetta, Kati P. Strzelczyk
The Beauty and the Terror of Agile Software Development
March 24, 2021 | Advisory | By Alex Civetta, Garrett Galvin
News & Press
Mintz Advises Cultivo in $14M Series A Funding
January 31, 2024
A Mintz team led by Tom Burton and Alex Civetta advised Cultivo Land PBC on its recent $14 million Series A funding round, bringing the company to over $20 million. This investment will be used to advance the growth of Cultivo’s AI platform for large scale nature regeneration projects, specifically focused on carbon removal, biodiversity enhancement, and improved water storage.
Twenty-Five Mintz Attorneys Named To Boston Magazine’s Top Lawyers List
November 21, 2023
BOSTON – Twenty-five Mintz attorneys have been named to Boston Magazine’s Top Lawyers list.
Fifty-Nine Attorneys Recognized as 2023 Massachusetts Super Lawyers and Rising Stars
October 12, 2023
Mintz is pleased to announce that 32 attorneys have been named Massachusetts Super Lawyers and 27 attorneys have been named Massachusetts Rising Stars for 2023.
Mintz is pleased to announce that 120 firm attorneys have been recognized as leaders by Best Lawyers® in the 2024 edition of The Best Lawyers in America©.
Mintz and ML Strategies Receive Environmental Business Council Award For Outstanding Collaboration
June 08, 2023
BOSTON - Mintz and ML Strategies were recognized with the prestigious Nicholas Humber Award for Outstanding Collaboration by the Environmental Business Council of New England (EBC) at the 30th Annual EBEE Awards in Boston.
BOSTON –Mintz announced today that 39 of its practices and 81 of its attorneys earned recognition in the 2023 edition of Chambers USA, a guide to the country’s leading law firms.
Twenty-Eight Mintz Attorneys Named To Boston Magazine’s Top Lawyers List
November 22, 2022
In its second annual edition, 28 Mintz attorneys were named to Boston Magazine’s Top Lawyers list.
Mintz took lead role for long-term client NanoView Biosciences in its sale to Unchained Labs, a portfolio company of The Carlyle Group. NanoView, through its ExoView technology, characterizes exosomes and the company’s LentiView platform complements Unchained Labs’ tools for gene therapy researchers working with lentivirus, which is an immunodeficiency virus that causes AIDS.
Events & Speaking
Negotiating Strategic Partnerships
Harvard Business School Rock Center for Entrepreneurship
Recognition & Awards
Chambers USA: Start Ups and Emerging Companies (2022-2024)
Best Lawyers: Ones to Watch - Technology Law (2024)
Boston Magazine Top Lawyers – Corporate Law (2021, 2022)
Massachusetts Supreme Judicial Court's Pro Bono Honor Roll (2021)
Massachusetts Super Lawyers: Technology Transactions (2023)